Gino Bottino, MD
Hematology & Oncology Physician · Tucson, AZ
Gino Bottino, MD is a hematology & oncology physician with a practice address in Tucson, Arizona, and NPI 1881705838, issued on Aug 31, 2006. Check the license on the Arizona Medical Board; the Medicare figures below come from public CMS files.
- Name
- Gino Bottino
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- 55107 CA
C1-0025452 DE
137196-1 NY
Self-reported in NPPES; status is on the state search - Practice location
- 1701 W Saint Marys RD Ste 100, Tucson, AZ 85745
- Phone
- (520) 276-2270
- Enumerated
- Aug 31, 2006
- Record last updated
- Nov 1, 2022
- Fax
- (520) 585-5827
- Medicaid ID
- 00826499 NY
- Medicare enrollment
- Enrolled (PECOS I20031103000508); accepts Medicare assignment
- Medical or professional school
- New York Medical College, 1977
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 285 in Arizona → Look up another NPI →
Also registered at 1701 W Saint Marys RD Ste 100
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Akshay Amaraneni, MDHematology & Oncology Physician1306285267
- Jaspreet Chahal, MDHematology & Oncology Physician1558703801
- John Migliano, MDHematology & Oncology Physician1932545746
Verify Gino Bottino in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersArizona Medical BoardCheck the board
- 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
48% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
459 Medicare Part D claims for 109 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 42% of claims.
Most prescribed
- Anastrozole65 claims
- Eliquis60 claims
- Letrozole39 claims
- Xtandi27 claims
- Hydroxyurea26 claims
- Acyclovir23 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $537.21
17 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Maimonides Faculty Practice PlanBrooklyn, NY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Gino Bottino among 285 hematology & oncology physician records in Arizona
Gino Bottino, MD is one of 285 hematology & oncology physician records with a practice address in Arizona. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 8% of them.
- NPI issued2006 · 8% of these records are older, 58% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 80% of these records are
- Graduated1977 · median 2003 among the 229 with a school on file
- Record last updated2022 · 37% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Arizona practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Arizona
There are 285 hematology & oncology physician records in Arizona.
All 285 in Arizona → Every provider in Tucson → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Lata Aluri, MDTucson, AZ 857451467581736
- Akshay Amaraneni, MDTucson, AZ 857451306285267
- Jaspreet Chahal, MDTucson, AZ 857451558703801
- Susannah Cooper, MDTucson, AZ 857451790846038
- Jai Joshi, MDTucson, AZ 857451700849346
- John Migliano, MDTucson, AZ 857451932545746
- Shamudheen Mohammed Rafiyath, M.D.Tucson, AZ 857471528202900
- Yusuf Ahmad, M.D.Oro Valley, AZ 857371467421131
Common questions
What is Gino Bottino, MD's NPI number?
Gino Bottino, MD's National Provider Identifier (NPI) is 1881705838, issued on Aug 31, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Gino Bottino, MD located?
The NPPES record lists a practice address at 1701 W Saint Marys RD Ste 100, Tucson, AZ, 85745. Phone: (520) 276-2270. Providers update this record themselves, so call before visiting.
How can I verify Gino Bottino, MD's license?
Search the Arizona Medical Board at https://www.azmd.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Gino Bottino, MD prescribe under Medicare Part D?
In 2024, Gino Bottino, MD had 459 Medicare Part D claims for 109 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.